SAGA Metals Completes Field Program at North Wind Iron Ore Project and Lists on Frankfurt Stock Exchange
VANCOUVER, British Columbia, Oct. 03, 2024 (GLOBE NEWSWIRE) — SAGA Metals Corp. (“TSXV: SAGA”) (“FSE: 20H”) (“SAGA” or the “Company”), […]
Grayscale Investments® Launches Grayscale® Aave Trust
STAMFORD, Conn., Oct. 03, 2024 (GLOBE NEWSWIRE) — Grayscale Investments®, an asset management firm with expertise in crypto investing, offering […]
AMERANT BANK EARNS SPOT ON NEWSWEEK’S 2024 LIST OF AMERICA’S MOST LOVED WORKPLACES FOR THE THIRD CONSECUTIVE YEAR
Miami, FL, Oct. 03, 2024 (GLOBE NEWSWIRE) — Newsweek recently announced their annual rankings of 2024 America’s Top Most Loved […]
Minerals Technologies Announces Third Quarter 2024 Conference Call
NEW YORK, Oct. 03, 2024 (GLOBE NEWSWIRE) — Minerals Technologies Inc. (NYSE: MTX) (“MTI” or “the Company”) announced today that it […]
Le CN divulguera ses résultats financiers et d’exploitation du troisième trimestre de 2024 le 22 octobre 2024
MONTRÉAL, 03 oct. 2024 (GLOBE NEWSWIRE) — Le CN (TSX : CNR) (NYSE : CNI) divulguera ses résultats financiers et d’exploitation du troisième […]
CN to Report Third-Quarter 2024 Financial and Operating Results on October 22, 2024
MONTREAL, Oct. 03, 2024 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) will issue its third-quarter 2024 financial and operating […]
TSX News -
TC Transcontinental’s Near-Term Emissions Targets Approved by the Science Based Targets initiative (SBTi)
MONTRÉAL, Oct. 03, 2024 (GLOBE NEWSWIRE) — Transcontinental inc. (TSX: TCL.A TCL.B) announces an important milestone in its sustainability journey. […]
AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis
OCALA, Fla., Oct. 03, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that […]
Kane Biotech to Participate in a Multinational Corporate Collaboration Project
WINNIPEG, Manitoba, Oct. 03, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) […]
Teva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate
The expansion of the strategic partnership reinforces the solid foundation of the collaborative efforts that commenced in April 2024 The […]
